- Home
- EXK vs LGND Comparison
EXK vs LGND Comparison
Compare EXK & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXK | LGND |
|---|---|---|
| Founded | 1981 | 1987 |
| Country | Canada | United States |
| Employees | N/A | 68 |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXK | LGND |
|---|---|---|
| Price | $8.88 | $195.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $13.94 | ★ $245.86 |
| AVG Volume (30 Days) | ★ 10.4M | 183.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $75.65 | $1.50 |
| Revenue Next Year | $11.63 | $18.28 |
| P/E Ratio | ★ N/A | $76.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.95 | $93.58 |
| 52 Week High | $15.15 | $227.92 |
Technical Indicators
Market Signals| Indicator | EXK | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 37.59 | 44.28 |
| Support Level | $8.33 | $179.55 |
| Resistance Level | $10.20 | $207.72 |
| Average True Range (ATR) | 0.60 | 10.02 |
| MACD | -0.16 | -1.59 |
| Stochastic Oscillator | 21.03 | 3.39 |
Price Performance
Historical ComparisonAbout EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.